Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

Does size matter in R&D productivity? If not, what does?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Factors not correlated with success or failure in drug development.
Figure 2: Factors correlated with success or failure in drug development.

References

  1. Dimasi, J. A. & Grabowski, H. G. “The cost of biopharmaceutical R&D: is biotech different?” Managerial Decision Econom. 28, 469–479 (2007).

    Article  Google Scholar 

  2. Pisano, G. P. Science Business: The Promise, The Reality, and the Future of Biotech 1–256 (Harvard Business School, 2006).

    Google Scholar 

  3. Morgan, P. et al. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival. Drug Discov. Today 17, 419–424 (2012).

    Article  CAS  Google Scholar 

  4. Morieux, Y. Smart rules: six ways to get people to solve problems without you. Harv. Bus. Rev. 89, 78–84, 86, 136 (2011).

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the contributions of P. Swiatek, N. Srikanth, M. Herant, R. Howard and especially Y. Morieux to this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Ringel.

Ethics declarations

Competing interests

The authors of this article are employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies on R&D productivity issues. The research for this specific article was funded by BCG's Health Care practice.

Supplementary information

Supplementary information S1 (box)

Dataset and analysis methods (PDF 352 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ringel, M., Tollman, P., Hersch, G. et al. Does size matter in R&D productivity? If not, what does?. Nat Rev Drug Discov 12, 901–902 (2013). https://doi.org/10.1038/nrd4164

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4164

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research